Mangoceuticals appoints Amanda Hammer as COO; CEO salary raised to $300k

MANGOCEUTICALS, INC.

Amanda Hammer appointed COO effective May 1, 2023; replaces Jonathan Arango who remains President/Secretary/Board member.
COO receives $150k annual salary, 75k vested common shares, and options for 150k shares at $1.10 strike.
CEO Jacob Cohen's salary increased from $180k to $300k per year, effective May 1, 2023.
Hammer previously served as director of e-Commerce since Oct 2022; prior COO at D Magazine Partners.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Amanda Hammer

Chief Operating Officer

MGRX · MANGOCEUTICALS, INC.

Effective: 2023-05-01
Filed: May 4, 2023, 7:59 PM ET

Effective on May 1, 2023, the Board of Directors of Mangoceuticals, Inc. (the “ Company ”, “ we ” and “ us ”) appointed Mrs. Amanda Hammer, as the Chief Operating Officer (COO) of the Company.

Role change

Jonathan Arango

Chief Operating Officer

MGRX · MANGOCEUTICALS, INC.

Effective: 2023-05-01
Successor: Amanda Hammer
Filed: May 4, 2023, 7:59 PM ET

As a result of such appointment Jonathan Arango, the President, Secretary and member of the Board of Directors of the Company, ceased serving as COO, but will continue serving in his other roles with the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Amanda Hammer was appointed as Chief Operating Officer at MANGOCEUTICALS, INC..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

Effective on May 1, 2023, the Board of Directors of Mangoceuticals, Inc. (the “ Company ”, “ we ” and “ us ”) appointed Mrs. Amanda Hammer, as the Chief Operating Officer (COO) of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan Arango changed role as Chief Operating Officer at MANGOCEUTICALS, INC..

Action: ceased serving as
Role: Chief Operating Officer

Exact text from the filing

As a result of such appointment Jonathan Arango, the President, Secretary and member of the Board of Directors of the Company, ceased serving as COO, but will continue serving in his other roles with the Company.

View on SEC.gov

MANGOCEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-015389

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.